Neovasc (NVCN) Agrees to Sell Tissue Processing Tech to Boston Scientific (BSX) in $75M Deal

December 2, 2016 7:03 AM EST Send to a Friend
Neovasc Inc. (Nasdaq: NVCN) announced that Boston Scientific Corporation (NYSE: BSX), a global medical technology leader, has agreed to acquire ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login